Allele buys CA plant for ‘footprint free’ stem cell production – BioPharma-Reporter.com
BioPharma-Reporter.com |
Allele buys CA plant for 'footprint free' stem cell production
BioPharma-Reporter.com The site will make clinical-grade stem cells using the firm's synthetic mRNA platform which Wang said avoids common problems associated with other stem cell generating platforms. “Our technology is 'footprint-free,'” Wang explained. “We send a message … |
